Cognex Corporation's (NASDAQ:CGNX) Intrinsic Value Is Potentially 39% Above Its Share Price

In This Article:

Key Insights

  • Using the 2 Stage Free Cash Flow to Equity, Cognex fair value estimate is US$41.30

  • Cognex's US$29.72 share price signals that it might be 28% undervalued

  • Analyst price target for CGNX is US$37.12 which is 10% below our fair value estimate

How far off is Cognex Corporation (NASDAQ:CGNX) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by estimating the company's future cash flows and discounting them to their present value. This will be done using the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex.

Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Is Cognex Fairly Valued?

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars:

10-year free cash flow (FCF) forecast

2025

2026

2027

2028

2029

2030

2031

2032

2033

2034

Levered FCF ($, Millions)

US$178.0m

US$210.0m

US$252.6m

US$295.0m

US$327.0m

US$354.7m

US$378.8m

US$400.2m

US$419.6m

US$437.5m

Growth Rate Estimate Source

Analyst x10

Analyst x10

Analyst x3

Analyst x1

Est @ 10.84%

Est @ 8.47%

Est @ 6.81%

Est @ 5.65%

Est @ 4.84%

Est @ 4.27%

Present Value ($, Millions) Discounted @ 7.5%

US$166

US$182

US$203

US$221

US$228

US$230

US$229

US$225

US$219

US$213

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = US$2.1b